Lister Troy
Insider CIK 2023489 · VERV Chief Scientific Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| VERV Verve Therapeutics, Inc. | D To issuer deriv | 2025-07-25 | 2025-07-28 | 32,000 | — | $0 | 0 | SEC↗ |
| VERV Verve Therapeutics, Inc. | D To issuer deriv | 2025-07-25 | 2025-07-28 | 69,500 | — | $0 | 0 | SEC↗ |
| VERV Verve Therapeutics, Inc. | D To issuer deriv | 2025-07-25 | 2025-07-28 | 12,075 | — | $0 | 0 | SEC↗ |
| VERV Verve Therapeutics, Inc. | D To issuer deriv | 2025-07-25 | 2025-07-28 | 40,000 | — | $0 | 0 | SEC↗ |
| VERV Verve Therapeutics, Inc. | D To issuer deriv | 2025-07-25 | 2025-07-28 | 6,630 | — | $0 | 0 | SEC↗ |
| VERV Verve Therapeutics, Inc. | D To issuer deriv | 2025-07-25 | 2025-07-28 | 225,000 | — | $0 | 0 | SEC↗ |
| VERV Verve Therapeutics, Inc. | U Tender | 2025-07-25 | 2025-07-28 | 6,952 | — | $0 | 0 | SEC↗ |
| VERV Verve Therapeutics, Inc. | S Sale | 2025-04-02 | 2025-04-03 | 2,189 | $4.15 | $9.1K | 6,952 | SEC↗ |
| VERV Verve Therapeutics, Inc. | M Exercise deriv | 2025-04-01 | 2025-04-03 | 4,025 | — | $0 | 12,075 | SEC↗ |
| VERV Verve Therapeutics, Inc. | M Exercise deriv | 2025-04-01 | 2025-04-03 | 3,315 | — | $0 | 6,630 | SEC↗ |
| VERV Verve Therapeutics, Inc. | M Exercise | 2025-04-01 | 2025-04-03 | 7,340 | — | $0 | 9,141 | SEC↗ |
| VERV Verve Therapeutics, Inc. | A Award deriv | 2025-01-08 | 2025-01-10 | 225,000 | — | $0 | 225,000 | SEC↗ |
| VERV Verve Therapeutics, Inc. | A Award deriv | 2025-01-08 | 2025-01-10 | 40,000 | — | $0 | 40,000 | SEC↗ |
| VERV Verve Therapeutics, Inc. | A Award deriv | 2024-06-21 | 2024-06-25 | 32,000 | — | $0 | 32,000 | SEC↗ |